DNA Sequencing

Global Market Trajectory & Analytics

MCP11607

EXECUTIVE ENGAGEMENTS

OUTREACH

1669
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

302
Interactions with Platform & by Email

PARTICIPANTS

67
Unique # Participated

VALIDATIONS

13
Responses Validated*

COMPETITORS

42
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

120

PAGES

192

EDITION

9

PRICE

USD 4950


  

HIGHLIGHTS

Amid the COVID-19 crisis, the global market for DNA Sequencing estimated at US$9.4 Billion in the year 2020, is projected to reach a revised size of US$28.8 Billion by 2027, growing at a CAGR of 17.3% over the analysis period 2020-2027. Diagnostics, one of the segments analyzed in the report, is projected to record a 17.7% CAGR and reach US$7.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Discovery segment is readjusted to a revised 15.1% CAGR for the next 7-year period.
The DNA Sequencing market in the U.S. is estimated at US$2.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$5 Billion by the year 2027 trailing a CAGR of 16.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15.5% and 14.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 12.6% CAGR.
In the global Biomarker Discovery segment, USA, Canada, Japan, China and Europe will drive the 17.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.5 Billion in the year 2020 will reach a projected size of US$7.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.5 Billion by the year 2027.

SELECT PLAYERS

Agilent Technologies, Inc.; Thermo Fisher Scientific, Inc.; Illumina, Inc.; QIAGEN; F. Hoffmann-La Roche Ltd.; Oxford Nanopore Technologies Ltd.; Macrogen, Inc.; Perkin Elmer, Inc.; Pacific Biosciences of California, Inc.; BGI; Bio-Rad Laboratories, Inc.; Myriad Genetics; PierianDx; Intrexon Bioinformatics Germany GmbH; Eurofins Scientific

SEGMENTS

» Application (Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research, Other Applications) » End-Use (Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics, Other End-Uses)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
How Genome Sequencing Combats COVID-19
Genome Sequencing: The Critical Method that Tracks Coronavirus Movement in Communities
An Introduction to DNA Sequencing
Methods of DNA Sequencing
Key Applications of DNA Sequencing
Development of New Sequencing Methods
Global Market Prospects & Outlook
Key Market Drivers
Consumables to Dominate Market Share
Third-Generation Sequencing Methods Exhibiting Fastest Growth
Academic Research: The Key End-Use Segment
While North America Dominates, Asia-Pacific to Grow Fastest
Competitive Landscape
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Next-Generation Sequencing: Key to Genetic Studies
Technological Advancements in DNA Sequencing Benefits Market Growth
Increasing Application in Drug Discovery
Legal and Ethical Issues Expected to Limit Market Growth
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for DNA Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Biomarker Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Biomarker Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biomarker Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Personalized Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Agriculture & Animal Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Agriculture & Animal Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Agriculture & Animal Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Research Centers and Academic & Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Research Centers and Academic & Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Research Centers and Academic & Government Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
USA Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
China Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for DNA Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for DNA Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for DNA Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
France Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
UK Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for DNA Sequencing by Application - Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for DNA Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery, Biomarker Discovery, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for DNA Sequencing by End-Use - Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for DNA Sequencing by End-Use - Percentage Breakdown of Value Sales for Research Centers and Academic & Government Institutes, Biotechnology Companies, Pharmaceutical, Hospitals & Clinics and Other End-Uses for the Years 2012, 2020 & 2027
Total Companies Profiled: 42

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com